Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial

Published:2015-07-24 Issue:3 Volume:8 Page:416-434
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

Milenic Diane,Molinolo Alfredo,Solivella María,Banaga Eileen,Torgue Julien,Besnainou Sarah,Brechbiel Martin,Baidoo Kwamena

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

http://www.mdpi.com/1424-8247/8/3/416/pdf

Reference27 articles.

1. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1;Horak;J. Nucl. Med.,1997

2. Evaluation of cetuximab as a candidate for targeted alpha-particle radiation therapy of HER1-positive disseminated intraperitoneal disease;Milenic;MAbs,2015

3. Evaluation of platinum chemotherapy in combination with HER2-targeted alpha-particle radiation;Milenic;Cancer Biother. Radiopharm.,2013

4. Potentiation of high-LET radiation by gemcitabine: Targeting HER2 with trastuzumab to treat disseminated peritoneal disease;Milenic;Clin. Cancer Res.,2007

5. Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a 212Pb-labeled radioimmunoconjugate targeting HER2;Milenic;Cancer Biother. Radiopharm.,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models;Frontiers in Chemistry;2024-01-25

2. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results;International Journal of Molecular Sciences;2024-01-04

3. ²¹²Pb-Pretargeted Theranostics for Pancreatic Cancer;Journal of Nuclear Medicine;2023-11-09

4. First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study);Frontiers in Medicine;2023-03-01

5. Bone Marrow Relative Biological Effectiveness for a 212Pb-labeled Anti-HER2/neu Antibody;International Journal of Radiation Oncology*Biology*Physics;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3